| 01.05 22:15 | BUSINESS WIRE: IFF Declares Dividend for Second Quarter 2024 |
| 16.04 22:15 | BUSINESS WIRE: IFF to Release First Quarter 2024 Results on May 6, 2024 |
| 03.04 06:00 | BUSINESS WIRE: IFF Completes Divestiture of Cosmetics Ingredients Business |
| 21.03 11:45 | BUSINESS WIRE: IFF Names Ana Paula Mendonça President, Scent |
| 19.03 11:45 | BUSINESS WIRE: IFF Announces Sale of its Pharma Solutions Business to Roquette |
| 01.03 22:15 | BUSINESS WIRE: IFF Announces Grant of Employment Inducement Awards |
| 29.02 22:15 | BUSINESS WIRE: IFF Named Top Company in the U.S. for Gender Equality in 2024 |
| 20.02 22:38 | BUSINESS WIRE: IFF Reports Fourth Quarter and Full Year 2023 Results |
| 24.01 22:15 | BUSINESS WIRE: IFF to Release Fourth Quarter and Full Year 2023 Results on Feb. 20, 2024; IFF to Present at 2024 CAGNY Conference on Feb. 22, 2024 |
| 19.01 13:14 | BUSINESS WIRE: IFF Partners with Environmental NGO Bellona to Restore Norwegian Seaweed Forests |
| 17.01 14:15 | Britische Kartellwächter erweitern Untersuchung gegen Duftstoffhersteller |
| 11.01 22:15 | BUSINESS WIRE: IFF Appoints J. Erik Fyrwald as Chief Executive Officer and Board Director; Reaffirms Full Year 2023 Financial Guidance |
| 06.11 22:18 | BUSINESS WIRE: IFF Reports Third Quarter 2023 Results |
| 06.11 22:15 | BUSINESS WIRE: IFF Announces Continuation of Cooperation Agreement with Icahn Capital |
| 02.11 21:15 | BUSINESS WIRE: IFF Declares Dividend for Fourth Quarter 2023 |
| 30.10 06:00 | BUSINESS WIRE: IFF Announces Clariant Has Agreed to Purchase IFF’s Cosmetic Ingredients Business Unit |
| 24.10 22:15 | BUSINESS WIRE: IFF to Release Third Quarter 2023 Results November 6 |
| 24.08 09:19 | AKTIE IM FOKUS 2: Symrise gefragt - Morgan Stanley lobt Perspektiven/Hochstufung |
| 21.08 22:15 | BUSINESS WIRE: IFF to Webcast Fireside Chat at Barclays Global Consumer Staples Conference on Sept. 7 |
| 03.08 22:15 | BUSINESS WIRE: IFF Announces Dr. Casper Vroemen to Succeed Dr. Gregory Yep as Chief R&D and Sustainability Officer |
|
|
